The Correlation between Retinal and Choroidal Thickness with Age-Related White Matter Hyperintensities in Progressive Supranuclear Palsy.

choroid neuroradiology optical coherence tomography progressive supranuclear palsy retina white matter age-related changes

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
22 Oct 2023
Historique:
received: 23 09 2023
revised: 11 10 2023
accepted: 19 10 2023
medline: 28 10 2023
pubmed: 28 10 2023
entrez: 28 10 2023
Statut: epublish

Résumé

Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease. Recently, several retinal layers in PSP compared to healthy controls. were found to be thinner. However, no studies evaluating the correlation between retinal layers and cerebral white matter changes, nor eventual choroidal changes in PSP, have been conducted so far. The goals of the present study were to explore potential differences in choroidal structure between PSP and healthy controls, and to describe the relationship between retinal layers' thickness and volume, using spectral-domain optical coherence tomography (SD-OCT) and age-related white matter change scores (ARWMC) using magnetic resonance imaging (MRI) of the brain. Choroidal structures of 26 PSP patients and 26 healthy controls using standard SD-OCT with an enhanced depth imaging (EDI) approach were analyzed; then, retinal the structures of 16 of these PSP patients using standard SD-OCT were examined; finally, the same patients underwent brain MRI, and their cerebral white matter changes were calculated. Non-statistically significant differences between PSP patients' and healthy controls' choroidal structure were found. On the contrary, PSP patients' inner retinal layers (INR), retinal pigmented epithelium (RPE) and all retinal layers' thicknesses in the macular region were found to be significantly correlated with ARWMC, independently from age and axial length (AL). PSP patients' neurological alterations go hand in hand with retinal ones, independently from age and axial length. Our results suggest a mutual relationship between cerebral and retinal structure pathological alterations. On the other hand, no significant differences in the choroidal evaluation compared to healthy controls have been found.

Identifiants

pubmed: 37892809
pii: jcm12206671
doi: 10.3390/jcm12206671
pmc: PMC10607459
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Lancet Neurol. 2013 Aug;12(8):822-38
pubmed: 23867200
J Neuroophthalmol. 2018 Jun;38(2):151-155
pubmed: 29240574
Stroke. 2001 Jun;32(6):1318-22
pubmed: 11387493
Graefes Arch Clin Exp Ophthalmol. 2020 Dec;258(12):2729-2736
pubmed: 32875394
Sci Rep. 2021 Apr 26;11(1):8936
pubmed: 33903644
Retina. 2013 Oct;33(9):1971-6
pubmed: 23644561
Sci Rep. 2021 Aug 12;11(1):16398
pubmed: 34385516
Ophthalmol Retina. 2020 Feb;4(2):204-215
pubmed: 32033714
Sci Rep. 2022 Mar 7;12(1):3660
pubmed: 35256658
Ophthalmic Physiol Opt. 2015 Jul;35(4):352-76
pubmed: 26094831
Ophthalmol Sci. 2021 Jun 10;1(2):100033
pubmed: 36249300
Front Aging Neurosci. 2021 Mar 16;13:625874
pubmed: 33815089
Prog Retin Eye Res. 2020 Jul;77:100829
pubmed: 31927136
Ophthalmol Sci. 2021 Dec 20;2(1):100098
pubmed: 36246183
Int J Environ Res Public Health. 2023 Jan 09;20(2):
pubmed: 36673897
PLoS One. 2012;7(4):e34891
pubmed: 22514688
Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
J Neural Transm (Vienna). 2014 Jan;121(1):41-7
pubmed: 23907408
Int J Dev Biol. 2004;48(8-9):1045-58
pubmed: 15558494
JAMA Ophthalmol. 2021 Feb 1;139(2):182-188
pubmed: 33355613
J Neurol. 2022 Jun;269(6):3216-3225
pubmed: 34921616
Mov Disord. 2020 Jun;35(6):984-993
pubmed: 32125724
J Ophthalmol. 2023 May 11;2023:2209496
pubmed: 37215947
Retina. 2014 Apr;34(4):768-74
pubmed: 24013259
Curr Opin Neurol. 2019 Feb;32(1):82-91
pubmed: 30566412
Neurol Sci. 2022 Aug;43(8):4803-4809
pubmed: 35411501
J Anat. 2005 Apr;206(4):319-48
pubmed: 15817102
Int Ophthalmol. 2022 May;42(5):1437-1445
pubmed: 34859311
Lancet Neurol. 2017 Jul;16(7):552-563
pubmed: 28653647
J Clin Med. 2023 Feb 28;12(5):
pubmed: 36902698
Invest Ophthalmol Vis Sci. 2011 Oct 31;52(11):8438-41
pubmed: 21917938
J Clin Med. 2023 Feb 14;12(4):
pubmed: 36836042
Sci Rep. 2022 Nov 7;12(1):18845
pubmed: 36344612
J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):98-103
pubmed: 31527182
Am J Ophthalmol. 2015 Jun;159(6):1123-1131.e1
pubmed: 25790737
Sci Rep. 2017 Jul 13;7(1):5357
pubmed: 28706282
J Clin Med. 2022 Aug 12;11(16):
pubmed: 36012966
Curr Top Dev Biol. 2010;93:61-84
pubmed: 20959163
BMC Ophthalmol. 2018 May 29;18(1):127
pubmed: 29843668

Auteurs

Maddalena De Bernardo (M)

Eye Unit, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84084 Fisciano, Italy.

Francesco Diana (F)

Neuroradiology Unit, University Hospital San Giovanni di Dio e Ruggi d'Aragona, 84131 Salerno, Italy.
Interventional Neurology Department, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.

Marco Gioia (M)

Eye Unit, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84084 Fisciano, Italy.

Martina De Luca (M)

Eye Unit, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84084 Fisciano, Italy.

Maria Francesca Tepedino (MF)

Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84084 Fisciano, Italy.

Maria Teresa Pellecchia (MT)

Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84084 Fisciano, Italy.

Nicola Rosa (N)

Eye Unit, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84084 Fisciano, Italy.

Paolo Barone (P)

Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84084 Fisciano, Italy.

Marina Picillo (M)

Center for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84084 Fisciano, Italy.

Classifications MeSH